4th Wet AMD & Diabetic Eye Disease Drug Development

This Event has Passed

Tuesday, March 19, 2024 - 8:00 AM
to Thursday, March 21, 2024 - 3:00 PM

Add to Calendar

03/19/2024 08:00 AM 03/21/2024 03:00 PM America/Anguilla 4th Wet AMD & Diabetic Eye Disease Drug Development The 4ᵗʰ Wet AMD & Diabetic Eye Disease Drug Development Summit is returning to Boston this March to unite 70+ industry-based retinal vascular experts from the likes of Bayer, Boehringer Ingelheim, Genentech, Novartis and OcuTerra, at the only industry-dedicated forum to transform the potential of treatment of chronic, sight-threatening retinal vascular diseases to improve patient outcomes. Hear fresh perspectives from the new companies speaking at the 2024 meeting including Aviceda Therapeutics, Bayer, Boehringer Ingelheim, OcuTerra, Novartis, Genentech, and Adverum Biotechnologies and discover robust new content focusing on industry-specific topics such as new targets, in vivo and ... Details & Tickets: https://www.upcomingevents.com/boston/events/wyndham-boston-beacon-hill/4th-wet-amd-diabetic-eye-disease-drug-development-142208?ref=uceaddevent Wyndham Boston Beacon Hill, 5 Blossom Street, Boston, MA, 02114

Neighborhoods

Beacon Hill (Boston)
Downtown Crossing (Boston)
Government Center (Boston)
West End (Boston)

View Event Website »

The 4ᵗʰ Wet AMD & Diabetic Eye Disease Drug Development Summit is returning to Boston this March to unite 70+ industry-based retinal vascular experts from the likes of Bayer, Boehringer Ingelheim, Genentech, Novartis and OcuTerra, at the only industry-dedicated forum to transform the potential of treatment of chronic, sight-threatening retinal vascular diseases to improve patient outcomes. Hear fresh perspectives from the new companies speaking at the 2024 meeting including Aviceda Therapeutics, Bayer, Boehringer Ingelheim, OcuTerra, Novartis, Genentech, and Adverum Biotechnologies and discover robust new content focusing on industry-specific topics such as new targets, in vivo and in vitro models, retinal imaging and clinical biomarkers and new modalities for retinal and choroidal neovascularization.

Event Links

Website: https://go.evvnt.com/2121997-0

Tickets: https://go.evvnt.com/2121997-2

Brochure: https://go.evvnt.com/2121997-3

View Less